Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

A Novel in vitro Functional Analysis Method for CYP2C9 Protein

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

In Vitro Functional Analysis of 24 Novel Cyp2c19 Variants Recently Found in the Chinese Han Population

Expression and Characterization of Human Cytochrome P450 1A2

Expressing in Vitro and Functional Study of Human CYP2D6 Gene

FUNCTIONAL CHARACTERIZATION OF HUMAN CYP2C9 ALLELIC VARIANTS IN COS-7 CELLS

Construction of Eukaryotic Expression Plasmids Containing Green Fluorescent Protein Gene and CYP19 WT or Its Variants

Establishment of the Recombinant Human Cytochrome P450 2C9 Saccharomyces Cerevisiae Expression Systems in Vitro and the Impact of Gene Polymorphism on Drug-Drug Interactions

In Vitro Functional Characterization of 37 CYP2C9 Allelic Isoforms Found in Chinese Han Population.

[CYP2D61, CYP2D610 Co-Expressed with CYPOR in Bac-to-Bac Expression System and Activity Determination].

In Vitro and in Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population

Study Heterogenous Expression and Activity Determination of Human Cytochrome P450 2B6

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population.

[Heterogeneous expression of human CYP and its application in early stage of new drug research and development].

Identification And Functional Assessment Of A New Cyp2c9 Allelic Variant Cyp2c9(Star)59

Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants

Catalytic Activities of Human Cytochrome P450 2C91, 2C93 and 2C9*13

Quantitative Analysis of Cytochrome P450 Isoforms in Human Liver Microsomes by the Combination of Proteomics and Chemical Probe-Based Assay

Establishment of in vitro methods for evaluation of induction and inhibition of human CYP450 enzymes by drugs

Identification of a novel CYP2C9 gene mutation (1400T ＞ C) and assessment of its enzymatic activity in vitro